Share

April 2021; 7 (2) ArticleOpen Access

Phenotypic Spectrum of Seizure Disorders in MBD5-Associated Neurodevelopmental Disorder

Kenneth A. Myers, Carla Marini, Gemma L. Carvill, Amy McTague, Julie Panetta, Chloe Stutterd, Thorsten Stanley, Samantha Marin, John Nguyen, Carmen Barba, Anna Rosati, Richard H. Scott, Heather C. Mefford, Renzo Guerrini, Ingrid E. Scheffer
First published March 18, 2021, DOI: https://doi.org/10.1212/NXG.0000000000000579
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
835

Share

Article Information

vol. 7 no. 2 e579
DOI: 
https://doi.org/10.1212/NXG.0000000000000579
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2376-7839
History: 
  • Received October 22, 2020
  • Accepted in final form February 11, 2021
  • First Published March 18, 2021.
Copyright & Usage: 
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Kenneth A. Myers, MD, PhD,
    2. Carla Marini, MD, PhD (carla.marini{at}ospedaliriuniti.marche.it),
    3. Gemma L. Carvill, PhD (gemma.carvill{at}northwestern.edu),
    4. Amy McTague, PhD (a.mctague{at}ucl.ac.uk),
    5. Julie Panetta, MBBS (julpul99{at}gmail.com),
    6. Chloe Stutterd, MBBS (chloe.stutterd{at}vcgs.org.au),
    7. Thorsten Stanley, MBChB (thorsten.stanley{at}otago.ac.nz),
    8. Samantha Marin, MD (smarin2{at}exchange.hsc.mb.ca),
    9. John Nguyen, BSc (janguyen735{at}gmail.com),
    10. Carmen Barba, MD, PhD (carmen.barba{at}meyer.it),
    11. Anna Rosati, MD, PhD (anna.rosati{at}meyer.it),
    12. Richard H. Scott, MD (richard.scott{at}genomicsengland.co.uk),
    13. Heather C. Mefford, MD, PhD (hmefford{at}uw.edu),
    14. Renzo Guerrini, MD, FRCP (r.guerrini{at}meyer.it) and
    15. Ingrid E. Scheffer, MBBS, PhD (i.scheffer{at}unimelb.edu.au)
  1. Kenneth A. Myers, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Fonds de Recherches du Québec – Santé, 282228 and 295639, principal investigator, 2020-2024

    Research Support, Academic Entities:

    1. (1) Research Institute of the McGill University Health Centre.

    Research Support, Foundations and Societies:

    1. (1) Dravet Canada, (2) Koolen-de Vries Foundation, (3) Savoy Foundation, (4) Citizens United for Research in Epilepsy

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Carla Marini, MD, PhD (carla.marini{at}ospedaliriuniti.marche.it),
    3. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Gemma L. Carvill, PhD (gemma.carvill{at}northwestern.edu),
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Contributing Scientific Editor - Epilepsy Currents

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Stoke Therapeutics - Collaborative Research Grant

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. (1) NIH (NINDS) New Innovators Award (2) NIH (NINDS) Center without Walls: EpiMVP

    Research Support, Foundations and Societies:

    1. (1) Dravet Syndrome Foundation Research Award (2) Chicago Biomedical Consortium Catalyst Award

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Amy McTague, PhD (a.mctague{at}ucl.ac.uk),
    5. Scientific Advisory Boards:

    1. 1. Commercial- consultant to Biogen as member of scientific advisory board January 2021 2. Non-profit- kcnt1 foundation (parent group) member of scientific advisory board 3. Non-profit- Apollo London translational research network, member of scientific advisory board

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1. Commercial entity: travel expenses for speaking engagement from Eisai November 2019 2. Commercial identity : honorarium for speaking Biocodex £1000 July 2019 3. Non-profit: honorarium for speaking American Epilepsy Society £358 December 2020

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Commercial entity: consultancy for Biogen January 2021

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. Medical Research Council, MR/T007087/1, Clinician Scientist Fellowship, Principal Investigator. March 2020-March 2024. 2. NIHR Great Ormond Street Hospital Biomedical Research Centre Catalyst Fellowship, Principal Investigator. September 2018- March 2020.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. Young Epilepsy bequest. Joint principal investigator. September 2020. 2. Autistica project grant. Co-investigator. September 2020. 3. Rosetrees Trust Seedcorn Award. M810. Principal Investigator. October 2018- April 2020.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Julie Panetta, MBBS (julpul99{at}gmail.com),
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Chloe Stutterd, MBBS (chloe.stutterd{at}vcgs.org.au),
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Health and Medical Research Council of Australia Postgraduate Scholarship

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Thorsten Stanley, MBChB (thorsten.stanley{at}otago.ac.nz),
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. use of probiotics in prevention of allergy use of probiotics in prevention of mental illness

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. advised Nutricia/Danone on allergic implications of changes in formula contents

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Samantha Marin, MD (smarin2{at}exchange.hsc.mb.ca),
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Speaker honoraria from Biomarin

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. John Nguyen, BSc (janguyen735{at}gmail.com),
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Carmen Barba, MD, PhD (carmen.barba{at}meyer.it),
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate Editor, Epileptic Disorders

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Anna Rosati, MD, PhD (anna.rosati{at}meyer.it),
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Richard H. Scott, MD (richard.scott{at}genomicsengland.co.uk),
    13. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Heather C. Mefford, MD, PhD (hmefford{at}uw.edu),
    14. Scientific Advisory Boards:

    1. (1) Professional Advisory Board, Lennox Gastaut Foundation (2) Medical Genetics Advisory Board, Simons SPARK study (3) Scientific Advisory Board, Dravet Syndrome Foundation, SynGAP Research Fund, Coalition to Cure CHD2

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Science Translational Medicine, Associate Scientific Editor 2014-1015 (2) Epilepsy Currents, Clinical Science Editor 2015-present (3) GeneReviews, Molecular Editor, 2016-2017 (4) Human Molecular Genetics Editorial Board, 2017 - present (5) American Journal of Human Genetics, 2018 - present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. NIH/NINDS Grant NS069605 2. NIH/NINDS Grant NS068605 3. NIH/NINDS Grant NS077303 4. NIH/NINDS Grant NS077364 5. NIH/NINDS Grant NS077275 6. NIH/NICHD Grant HD000836

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  14. Renzo Guerrini, MD, FRCP (r.guerrini{at}meyer.it) and
    15. Scientific Advisory Boards:

    1. Honoraria for Advisory Board activities and travel related expenses for: (1) Eisai Inc, (2) Novartis, (3) Zogenix, (4) Biomarin, (5) UCB, (6) GW Pharma, (7) Biocodex.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) EISAI: funding for travel. (2) Novartis: funding for travel; (3) UCB: Funding for travel. (3) Biomarin: funding for travel, (4) Novartis: funding for travel, (5) GW funding for travel; (6) Zogenix: funding for traveling and reviewing scientific content of symposia.

    Editorial Boards:

    1. (1) Epilepsia: Associate Editor 2006-2013, (2) Progress in Epileptic Disorders, International Advisory Board, 2007- (3) Neuropediatrics, Editorial Board, 2001-2009 (4) Journal of Child Neurology, Editorial Board, 1995-2010, (5) Seizure, Editorial Board 2005-, (6) BMC Medical Genetics,Editorial Board, 2006-, (7) Topics in Epilepsy, Editorial Board, 2009- (8) Journal of Pediatric Epilepsy, Editorial Board, 2011- (9) Epileptic Disorders,Editorial Board, 1999-2012 (10) European Neurological Journal, Editorial Board, 2010- (11) Neurology, Editorial Board, 2013- (12) Journal of Embryology & Developmental Biology, 2016-

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Epilepsy and Movements disorders, Cambridge University Press, 2002, (2) Aicardi's Epilepsy in Children, Lippincott Williams & Wilkins, 2004, (3) Progress in Epileptic Spasms and West Syndrome, John Libbey Eurotext, 2007, (4) Epilepsy and Migraine, John Libbey Eurotext, 2009, (5) The Causes of Epilepsy, Cambridge University Press, 2011. (6) Dravet syndrome, John Libbey Eurotext, 2011. (7) Epilepsy and epileptic seizures, Oxford University Press, 2012. (8) The Causes of Epilepsy 2nd edition, Cambridge University Press, 2019. (9) Epilepsy syndromes in Infancy, Childhood and Adolescence. 6th Edition. John Libbey Eurotext, 2019.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) EU contract number LSH-CT-2006-2011 037315 (EPICURE) FP6 - LIFESCIHEALTH. Subproject Coordinator (2) Tuscany Region. Research Department. Drug treatment and neuroprotection in hypoxic-ischemic brain injury and neonatal– infantile seizures. 2010-2013. Project Coordinator. (3) EC PROGRAM Rare disease: use of clinical trial simulation for the choice and optimization of study Design: Era-Net. 2011 – 2014. Unit Coordinator. (4) EC. Genetics of cortical gyral dysgenesis and pathophysiology of tubulin-related malformations of cortical development. EU PROGRAM: E-RARE2. 2012-2014. Unit Coordinator. (5) EC FP7, 2013-2018. DESIRE: Development and Epilepsy - Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat Epilepsy. Grant Agreement 6602531; Project Coordinator, 2013-2018. Italian Ministry of Health and Tuscany Region: An integrated approach to unravel the genetic causes and molecular pathogenesis of epileptogenic focal cortical dysplasia. RF-2013-02355240. 2016-2019. Project Coordinator. DECODEE-Developmental and epileptic encephalopathies: epidemiology, comorbidities, molecular diagnosis, personalized management, and costs analysis. Health call 2018. Tuscany Region. Active 2020-2023. Project Coordinator.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Pisa Foundation. Grant Title: Development of technology for the diagnostic characterisation and post-chemotherapy- radiotherapy monitoring of paediatric brain tumours using ultra high field MRI. 2013-2016. Project Coordinator.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  15. Ingrid E. Scheffer, MBBS, PhD (i.scheffer{at}unimelb.edu.au)
    16. Scientific Advisory Boards:

    1. (1) GSK - Scientific Advisory Board 2018 (2) Xenon Pharmaceuticals - Scientific Advisory Board 2017 (3) BioMarin - Scientific Advisory Board 2017, 2018, 2019, 2020 (4) UCB - Scientific Advisory Board Chair 2017, 2019, 2020 (5) Eisai - Scientific Advisory Board (6) Rogcon - Scientific Advisory Board (7) Zynerba - Scientific Advisory Board 2020 (8) Chiesi - Scientific Advisory Board 2020 (9) Encoded Therapeutics - Scientific Advisory Board 2020 (10) Nutricia - Scientific Advisory Board 2017

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) GSK; Travel/Conference expenses. Honoraria, speaker 2017/2018 (2) BioMarin; Honoraria, Travel/Conference expenses 2017/2018/2019/2020/2021 (3) National Research Foundation, Singapore: Travel/conference expenses, honoraria 2018/2019 (4) Athena Diagnostics, Honoraria, Travel/Conference 2018 (5) Eisai: Honoraria, Travel/Conference 2017, 2021 (6) UCB: Travel/Conference (7) Biocodex, Honoraria, Travel/Conference

    Editorial Boards:

    1. (1) Neurology, Editorial Board, 2014-present (2) Epilepsy Currents, Editorial Board, 2014-present (3) Epileptic Disorders, Editorial Board, 2006-present (4) Annuals of Neurology, Editorial Board, 2007-2015 (5) Progress in Epileptic Disorders series, Editorial Board, 2005-present (6) Epilepsia, Editorial Board, 2001-2003, 2008-2010

    Patents:

    1. (1) Patent for SCN1A testing held by Bionomics Inc and licensed to various diagnostic companies (WO/2006/133508) (2) Patent for a molecular diagnostic/therapeutic target for benign familial infantile epilepsy (BFIE) [PRRT2] WO/2013/059884 with royalties paid (3) May accrue future revenue on pending patent WO2009/086591: Diagnostic And Therapeutic Methods For EFMR (Epilepsy And Mental Retardation Limited To Females)

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Ovid Therapeutics: 2018 (2) UCB: 2018 (3) Atheneum Partners: 2019 (4) Zynerba Pharmaceuticals: 2019-2020 (5) Bionomics: 2005-2005

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) GW Pharmaceuticals: Participated in Epilepsy Drug Consortium 2017/2020 and as a trial investigator 2017/2020 (2) Marinus: trial investigator 2019/2020 (3) Zynerba Pharmaceuticals: trial investigator 2018/2020 (4) UCB: trial investigator 2013/2019 (5) Ovid: trial investigator 2018/2020 (6) Zogenix: trial investigator 2016/2020 (7) Ultragenyx: trial investigator 2018-2019 (8) Eisai: trial investigator (9) Anavex Life Sciences: trial investigator 2020 (10) Encoded Therapeutics: trial investigator 2020 (11) Epygenyx: trial investigator

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) National Health and Medical Research Council, Australia: a) CI,Program Grant 2016-2020 b) CI, Practitioner Fellowship 2016-2020 c) CI, Project Grant 2016-2020 d) CI, Centre for Research Excellence Grant, 2016-2021 e) CI, Senior Investigator Fellowship 2020-2024 f) CI, Targeted Call for Research into Preparing Australia for the Genomics Revolution in Health Care 2016-2020 (2) National Institute of Health: a)PI, Centres without Walls funding 'Epi4K' 2016- 2020 (3) Medical Research Future Fund 2017-2021, 2020-2024 (4) Health Research Council New Zealand 2015-2018, 2020-2022 (5) Australian Epilepsy Research Fund 2020-2024

    Research Support, Academic Entities:

    1. National Health and Medical Research Council

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. Patent for a molecular diagnostic/therapeutic target for benign familial infantile epilepsy (BFIE) [PRRT2] WO/2013/059884 with royalties paid

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Research Institute of the McGill University Health Centre (K.M.), Montreal, PQ; Division of Child Neurology (K.M.), Department of Pediatrics, Montreal Children's Hospital, McGill University, Montreal, PQ; Department of Neurology & Neurosurgery (K.M.), Montreal Children's Hospital, McGill University, Montreal, PQ; Child Neurology and Psychiatry (C.M.), Salesi Pediatric Hospital, United Hospitals of Ancona, Ancona, Italy; Division of Genetic Medicine (G.L.C., J.N., H.C.M.), Department of Pediatrics, University of Washington, Seattle, WA; Department of Neurology (A.M.), Great Ormond Street Hospital for Children, London, UK; Developmental Neurosciences Programme (A.M.), UCL Great Ormond Street Institute of Child Health, London, UK; Neurology Network Melbourne (J.P.), Melbourne, Victoria, Australia; Murdoch Children's Research Institute (C.S., I.E.S.), Parkville, Victoria, Australia; Department of Paediatrics and Child Health (T.S.), School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand; Division of Neurology (S.M.), Department of Pediatrics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Neurology Unit and Neurogenetic Laboratories (C.B., A.R., R.G.), Meyer Children's Hospital, Florence, Italy; Department of Clinical Genetics (R.H.S.), Great Ormond Street Hospital, London, UK; Epilepsy Research Centre (I.E.S.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia; Department of Paediatrics (I.E.S.), Royal Children's Hospital, The University of Melbourne, Parkville, Victoria, Australia; and The Florey Institute of Neuroscience and Mental Health (I.E.S.), Heidelberg, Victoria, Australia.
  1. Correspondence
    Dr. Myers sfuken1{at}gmail.com
View Full Text

Article usage

Article usage: March 2021 to December 2022

AbstractFullPdfSource
Mar 20212615049Highwire
Apr 2021530961Highwire
May 2021118961Highwire
Jun 2021311950Highwire
Jul 2021107941Highwire
Aug 20211010136Highwire
Sep 2021313046Highwire
Oct 20211210570Highwire
Nov 202165646Highwire
Dec 202186339Highwire
Jan 202267440Highwire
Feb 2022410329Highwire
Mar 202267241Highwire
Apr 202205028Highwire
May 202227437Highwire
Jun 202268222Highwire
Jul 202216110Highwire
Aug 202248922Highwire
Sep 202256728Highwire
Oct 202266128Highwire
Nov 20221010334Highwire
Dec 202264917Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me